DPI-3290
Modify Date: 2024-01-09 19:09:24
DPI-3290 structure
|
Common Name | DPI-3290 | ||
|---|---|---|---|---|
| CAS Number | 182417-73-8 | Molecular Weight | 487.60800 | |
| Density | 1.161±0.06 g/cm3(Predicted) | Boiling Point | 620.4±55.0 °C(Predicted) | |
| Molecular Formula | C30H34FN3O2 | Melting Point | 144-145 °C | |
| MSDS | N/A | Flash Point | N/A | |
Use of DPI-3290DPI-3290 (Org 41793) is a potent and specific opioid receptors agonist with Ki values of 0.18 nM, 0.46 nM, and 0.62 nM for δ-, μ-, and κ-opioid receptors, respectively。DPI-3290 is one of a series of novel centrally acting agents with potent antinociceptive activity[1]. |
| Name | 3-[(R)-[(2S,5R)-2,5-dimethyl-4-prop-2-enylpiperazin-1-yl]-(3-hydroxyphenyl)methyl]-N-(3-fluorophenyl)-N-methylbenzamide |
|---|---|
| Synonym | More Synonyms |
| Description | DPI-3290 (Org 41793) is a potent and specific opioid receptors agonist with Ki values of 0.18 nM, 0.46 nM, and 0.62 nM for δ-, μ-, and κ-opioid receptors, respectively。DPI-3290 is one of a series of novel centrally acting agents with potent antinociceptive activity[1]. |
|---|---|
| Related Catalog | |
| Target |
IC50: 0.18 nM (δ-opioid receptor), 0.46 nM (μ-opioid receptor) and 0.62 nM (κ-opioid receptor)[1] |
| In Vivo | DPI-3290 (Org 41793) (intravenous; 0.05 mg/kg) produces a 50% antinociceptive response in rats[1]. |
| References |
| Density | 1.161±0.06 g/cm3(Predicted) |
|---|---|
| Boiling Point | 620.4±55.0 °C(Predicted) |
| Melting Point | 144-145 °C |
| Molecular Formula | C30H34FN3O2 |
| Molecular Weight | 487.60800 |
| Exact Mass | 487.26400 |
| PSA | 47.02000 |
| LogP | 5.35370 |
| Storage condition | 2-8°C |
| unii-r3uo4y068s |
| dpi-3290 |